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ThymomaAbstract Myocardial perfusion imaging (MPI) by 99mTc-sestamibi constitutes a major part of
nuclear medicine studies. Incidental detection of extracardiac abnormalities occurs not infrequently.
These can include benign and malignant lesions and their detection can be of great value in patient’s
future.
We present a 60 year-old man who underwent MPI to evaluate coronary artery disease as the pos-
sible cause of his chest discomfort. The images revealed a large area of intense increased tracer
uptake in the antero- inferior mediastinum that further evaluation confirmed to be a benign thy-
moma.
 2015 The Authors. The Egyptian Society of Radiology and Nuclear Medicine. Production and hosting
by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.
org/licenses/by-nc-nd/4.0/).1. Introduction
99mTc-sestamibi is a lipophilic cationic agent used mainly for
myocardial perfusion imaging (MPI). It localizes by passive
diffusion and intracellular retention. Non-cardiac normal tra-
cer uptake with various intensities can be seen in the lungs, lac-
tating breasts, liver, gallbladder and bowel. The incidence of
extracardiac incidental findings in SPECT studies of the heart
varies greatly from 0.69% non-cardiac findings by Jones et al.
to 22.55% intra-thoracic and intra-abdominal findings by Shin
et al. (1).Extracardiac pathologic uptake can occur in benign or
malignant tumors, infectious and non-infectious diseases.
Thymoma is a rare tumor (incidence rate: 0.15/100,000)
with a largely indolent growth pattern. It has malignant poten-
tial and can invade locally and metastasize regionally. Thymo-
mas constitute 20% of mediastinal tumors and are the most
common tumor of the anterior mediastinum. It typically pre-
sents in 4th or 5th decades of life. Fifty percent of patients
are asymptomatic and incidentally detected (2).
2. Case report
Our patient was a 60 year-old man with atypical chest pain and
hyperlipidemia who was referred for MPI. He performed exer-
cise test and 20 mCi 99mTc-MIBI was injected when he
achieved 90% of predicted maximum heart rate for his
age at the 3rd stage according to the Bruce protocol. Fifteen
108 S. Hekmat, N. Yaghoobiminutes after injection, SPECT images were obtained using a
single-headed MIE gamma camera, equipped with a LEAP
collimator. Images were acquired in a 180 degree arc in step
and shoot mode with 32 projections, matrix 64  64 and 25 s
per projection. Noting hypoactivity in the inferior wall on
the stress phase, we obtained a left lateral planar image in
addition to repeating the study in the prone position. No sig-
nificant inferior wall hypoactivity was detected on these addi-
tional images, approving the possibility of diaphragmatic
attenuation rather than ischemia in that region.
Rest images was obtained on the following day with the
same imaging parameters.
The reconstructed images showed no evidence of ischemia
(Fig. 1). But cinematic review of the raw data to check possibleFig. 1 Reconstructed myocardial perfusion SPECTmotion, revealed a large area of increased tracer uptake, isoac-
tive with the heart, in the right side of the lower mediastinum
on both phases of the study (Figs. 2 and 3). Chest X-ray and
CT scan were requested. CT scan showed a 90 * 73 mm well
defined enhancing soft tissue mass corresponding to the uptake
area (Figs. 4 and 5). The patient underwent biopsy and the
mass was proved to be a benign thymoma on histology. He
refused further surgical treatment.
3. Discussion
99mTc-sestamibi is widely used for MPI. It is also well-known
as a tumor-imaging agent. The exact mechanism of 99mTc-
MIBI uptake is not well known. It seems to be more closelyimages reveal no significant reversible ischemia.
Fig. 2 Raw data of the stress phase show a large area of
abnormal tracer accumulation in the mediastinum (arrow).
Fig. 3 Raw data of the rest study revealed a large area of
abnormal tracer accumulation in the mediastinum, identical to the
stress phase (arrow).
Fig. 4 Spiral lung CT scan without IV contrast.
Fig. 5 Spiral lung CT scan with IV contrast shows an enhancing
soft tissue mass in the right side of anterior mediastinum.
Unexpected large benign thymoma 109related to blood flow, tumor necrosis and mitochondrial activ-
ity rather than lesion status (benign or malignant) (3). It accu-
mulates in breast, thyroid, bone, brain and lung cancer (4) but
there are sporadic cases of 99mTc-MIBI uptake in patients
with anterior mediastinal mass. (5) In adults, main differential
diagnoses of masses in the anterior mediastinum include lym-
phoma and thymoma (6).
Tc-tetrofosmin is another radiopharmaceutical used for
MPI. Most of the reported abnormal extracardiac tracer accu-mulation during MPI had utilized this agent and there are
some reports of Tc-tetrofosmin uptake by benign thymomas
(7,8).
But rare reports of 99mTc-MIBI uptake by this kind of
tumor have been found. Vast majority of thymic tumors
reported as 99mTc-MIBI-avid are malignant thymomas, and
there are very rare reports in the literature showing 99mTc-
MIBI uptake in the benign thymoma. Adalet et al. (1995)
and Lanka et al. (2002), each reported one case. Erdogan
110 S. Hekmat, N. Yaghoobiet al. reported a 3.5  5 cm 99mTc-MIBI-avid thymoma in a
45 year old female during MPI (9).
Aydin et al. described a 5.5  1.5 cm thymoma in the upper
side of the heart in a 51 year old male (10).
No other reported case of this kind was found. Our case
was a large 99 mTc-MIBI-avid benign thymoma.
As was previously noted, there seems to be no direct rela-
tion between the intensity of 99 mTc-MIBI uptake and the
tumor histology of whether benign or malignant which is also
compatible with this case.
Hereby, we should re-emphasize that there is a vital role for
evaluating cinematic mode of raw MPI data to discover any
unexpected abnormal activity. 99 mTc-MIBI uptake could be
seen in masses, which are either benign or malignant. This
early detection, especially for malignant lesions is of critical
value for patient survival and medical cost.
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